172 related articles for article (PubMed ID: 34946056)
1. Susceptibility of Fluconazole-Resistant
Alshaikh NA; Perveen K
Microorganisms; 2021 Nov; 9(12):. PubMed ID: 34946056
[No Abstract] [Full Text] [Related]
2. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
3. The Inhibition of Non-
Mandras N; Roana J; Scalas D; Del Re S; Cavallo L; Ghisetti V; Tullio V
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443525
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
[TBL] [Abstract][Full Text] [Related]
5. Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida.
Mandras N; Nostro A; Roana J; Scalas D; Banche G; Ghisetti V; Del Re S; Fucale G; Cuffini AM; Tullio V
BMC Complement Altern Med; 2016 Aug; 16(1):330. PubMed ID: 27576581
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole resistant opportunistic oro-pharyngeal Candida and non-Candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria.
Enwuru CA; Ogunledun A; Idika N; Enwuru NV; Ogbonna F; Aniedobe M; Adeiga A
Afr Health Sci; 2008 Sep; 8(3):142-8. PubMed ID: 19357740
[TBL] [Abstract][Full Text] [Related]
8. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the Antifungal Potential of Two Iberian Thyme Essential Oils: Effect on
Alves M; Gonçalves MJ; Zuzarte M; Alves-Silva JM; Cavaleiro C; Cruz MT; Salgueiro L
Front Pharmacol; 2019; 10():446. PubMed ID: 31130859
[TBL] [Abstract][Full Text] [Related]
11. Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans.
Sharifzadeh A; Khosravi AR; Shokri H; Sharafi G
J Mycol Med; 2015 Jun; 25(2):143-50. PubMed ID: 25982599
[TBL] [Abstract][Full Text] [Related]
12. Synergistic potential of Citrus aurantium L. essential oil with antibiotics against Candida albicans.
Nidhi P; Rolta R; Kumar V; Dev K; Sourirajan A
J Ethnopharmacol; 2020 Nov; 262():113135. PubMed ID: 32693117
[TBL] [Abstract][Full Text] [Related]
13. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
14. Investigation of ERG11 gene expression among fluconazole-resistant Candida albicans: first report from an Iranian referral paediatric hospital.
Teymuri M; Mamishi S; Pourakbari B; Mahmoudi S; Ashtiani MT; Sadeghi RH; Yadegari MH
Br J Biomed Sci; 2015; 72(1):28-31. PubMed ID: 25906488
[TBL] [Abstract][Full Text] [Related]
15. Anti-Candida Activity of Bursera morelensis Ramirez Essential Oil and Two Compounds, α-Pinene and γ-Terpinene-An In Vitro Study.
Rivera-Yañez CR; Terrazas LI; Jimenez-Estrada M; Campos JE; Flores-Ortiz CM; Hernandez LB; Cruz-Sanchez T; Garrido-Fariña GI; Rodriguez-Monroy MA; Canales-Martinez MM
Molecules; 2017 Dec; 22(12):. PubMed ID: 29206158
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
17. Identification of Candida species in patients with oral lesion undergoing chemotherapy along with minimum inhibitory concentration to fluconazole.
Maheronnaghsh M; Tolouei S; Dehghan P; Chadeganipour M; Yazdi M
Adv Biomed Res; 2016; 5():132. PubMed ID: 27656601
[TBL] [Abstract][Full Text] [Related]
18. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
Pfaller MA; Messer SA; Hollis RJ; Jones RN; Doern GV; Brandt ME; Hajjeh RA
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):217-22. PubMed ID: 10212747
[TBL] [Abstract][Full Text] [Related]
19. High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Darma S; Ambara A; Aman AT; Annisa L; Nurrokhman ; Nuryastuti T; Wibawa T
PLoS One; 2020; 15(11):e0242542. PubMed ID: 33212470
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form.
D'Auria FD; Tecca M; Strippoli V; Salvatore G; Battinelli L; Mazzanti G
Med Mycol; 2005 Aug; 43(5):391-6. PubMed ID: 16178366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
